Breast implant infection with Mycobacterium fortuitum group: Report of case and review

Journal of Infection

Volumn 52, Issue 3, 2006, Pages

  Vinh, Donald C ^a   Rendina, Assunta ^b   Turner, Robert ^a   Embil, John M ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Atypical mycobacteria; Breast implant; Infection; Mycobacterium fortuitum

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; BACITRACIN; CEFAZOLIN; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; IMIPENEM; ISONIAZID; RIFAMPICIN; SULFAMETHOXAZOLE; TOBRAMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATION; BREAST AUGMENTATION; BREAST ENDOPROSTHESIS; BREAST RECONSTRUCTION; CASE REPORT; CLINICAL PROTOCOL; ERADICATION THERAPY; FEMALE; HOSPITAL DISCHARGE; HUMAN; MYCOBACTERIUM FORTUITUM; NONHUMAN; POSTOPERATIVE PERIOD; PROSTHESIS INFECTION; REOPERATION; REVIEW; SURGICAL TECHNIQUE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33344470231     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2005.07.004     Document Type: Article

References (25)

1. A.J. Mangram T.C. Horan M.L. Pearson L.C. Silver W.R. Jarvis Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee Am J Infect Control 27 2 1999 97-132
2. C.Y. Ahn C.Y. Ko E.A. Wagar R.S. Wong W.W. Shaw Microbial evaluation: 139 implants removed from symptomatic patients Plast Reconstr Surg 98 7 1996 1225-1229
3. H.W. Clegg M.T. Foster W.E. Sanders Jr W.B. Baine Infection due to organsims of the Mycobacterium fortuitum complex after augmentation mammaplasty: Clinical and epidemiologic features J Infect Dis 147 3 1983 427-433
4. C.L. Daley D.E. Griffith Pulmonary disease caused by rapidly growing mycobacteria Clin Chest Med 23 3 2002 623-632
5. R.J. Wallace Jr J.M. Swenson V.A. Silcox R.C. Good J.A. Tschen M.S. Stone Spectrum of disease due to rapidly growing mycobacteria Rev Infect Dis 5 4 1983 657-679
6. A.D. Widgerow A. Brink H.J. Koornhof Atypical Mycobacterium and breast surgery Ann Plast Surg 35 2 1995 204-207
7. J.B. Heistein J.E. Mangino R.L. Ruberg J.J. Bergese A prosthetic breast implant infected with Mycobacterium fortuitum Ann Plast Surg 44 3 2000 330-333
8. J. Haiavy H. Tobin Mycobacterium fortuitum infection in prosthetic breast implants Plast Reconstr Surg 109 6 2002 2124-2128
9. J. Rimmer S. Hamilton D. Gault Recurrent mycobacterial breast abscesses complicating reconstruction Br J Plast Surg 57 7 2004 676-678
10. R.J. Colville C.A. Mallen L. McLean N.R. McLean What is the impact of breast augmentation on the Breast Screening Programme? Eur J Surg Oncol 29 5 2003 434-436
11. American Society of Plastic Surgeons. 2002 Quick facts on cosmetic and reconstructive plastic surgery. Available at: http://www.plasticsurgery.org/public_education/loader.cfm?url=/ commonspot/security/getfile.cfm&PageID=6056. Accessibility verified December 18; 2003.
12. B.A. Brown-Elliott R.J. Wallace Jr Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria Clin Microbiol Rev 15 4 2002 716-746
13. K.L. Winthrop M. Abrams M. Yakrus I. Schwartz J. Ely D. Gillies et. al. An outbreak of Mycobacterial furunculosis associated with footbaths at a nail salon N Engl J Med 346 18 2002 1366-1371
14. I. Sermet-Gaudelus M. Le Bourgeois C. Pierre-Audigier C. Offredo D. Guillemot S. Halley et. al. Mycobacterium abscessus and children with cystic fibrosis Emerg Infect Dis 9 12 2003 1587-1591
15. R.J. Wallace Jr L.C. Steele A. Labidi V.A. Silcox Heterogeneity among isolates of rapidly growing mycobacteria responsible for infections following augmentation mammaplasty despite case clustering in Texas and other southern coastal states J Infect Dis 160 2 1989 281-288
16. T.J. Safranek W.R. Jarvis L.A. Carson LB. Cusick LA. Bland JM Swenson et. al. Mycobacterum chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution N Engl J Med 317 4 1987 197-201
17. Centers for Disease Control and Prevention (CDC) Nontuberculous mycobacterial infections after cosmetic surgery-Santo Domingo, Dominican Republic, 2003-2004 MMWR Morb Mortal Wkly Rep 53 23 2004 509
18. J. Murillo J. Torres L. Bofill A. Rios-Fabra E. Irausquin R Istúriz et. al. Skin and wound infection by rapidly growing mycobacteria Arch Dermatol 136 11 2000 1347-1352
19. H. Meyers B.A. Brown-Elliott D. Moore J. Curry C. Truong Y. Zhang et. al. An outbreak of Mycobacterium chelonae infection following liposuction Clin Infect Dis 34 11 2002 1500-1507
20. R.J. Wallace Jr J. Swenson V.A. Silcox MG. Bullen Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities J Infect Dis 152 3 1985 500-514
21. G.L. Woods B.A. Brown-Elliott E.P. Desmond GS. Hall L. Heifets GE. Pfyffer et. al. Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes; approved standard 2003 NCCLS p. M24-A
22. G.L. Woods Susceptibility testing for Mycobacteria Clin Infect Dis 31 5 2000 1209-1215
23. National Committee for Clinical Laboratory Standards. Susceptibility testing of mycobacteria, Nocardia, and other aerobic actinomycetes. 2d ed. Tentative standard M24-T2. Wayne, PA: National Committee for Clinical Laboratory Standards, 2000.
24. G.L. Woods J.S. Bergmann F.G. Witebsky GA Fahle B Boulet M Plaunt et. al. Multisite reproducibility of Etest for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum J Clin Microbiol 38 2 2000 656-661
25. J.C. Muthasami F.L. Vyas U. Mukundan M.R. Jesudason S. Govil S.R. Jesudason Mycobacterium fortuitum: An iatrogenic cause of soft tissue infection in surgery. ANZ J Surg 2003; 74(8):662-6